Premium
Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria
Author(s) -
Sabroe R.A.
Publication year - 2014
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.13074
Subject(s) - omalizumab , medicine , adverse effect , dermatology , immunoglobulin e , quality of life (healthcare) , ciclosporin , population , prednisolone , chronic urticaria , monoclonal , monoclonal antibody , immunology , antibody , chemotherapy , nursing , environmental health